Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sanders, Joyce"'
Autor:
Embaby A; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands. Electronic address: a.embaby@nki.nl., Heinhuis KM; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., IJzerman NS; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands., Koenen AM; Department of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., van der Kleij S; Department of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., Hofland I; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., van Boven H; Department of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands., Sanders J; Department of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands., van der Graaf WTA; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands., Haas RL; Department of Radiotherapy, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Pharmacology, Princess Màxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., van Houdt WJ; Department of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 May; Vol. 202, pp. 113974. Date of Electronic Publication: 2024 Mar 02.
Autor:
den Uil SH; Department of Surgery, Spaarne Gasthuis, Boerhaavelaan 22, 2035 RC, Haarlem, the Netherlands., de Wit M; Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands., Slebos RJC; Department of Head & Neck Oncology and Endocrinology, Clinical Science Laboratory, Moffitt Cancer Center, 13131 Magnolia Drive, Tampa, FL, 33612, USA., Delis-van Diemen PM; Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands., Sanders J; Department of Pathology, Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands., Piersma SR; Department of Medical Oncology, OncoProteomics Laboratory, Amsterdam UMC, VU University Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands., Pham TV; Department of Medical Oncology, OncoProteomics Laboratory, Amsterdam UMC, VU University Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands., Coupé VMH; Department of Epidemiology and Biostatistics, Amsterdam UMC, VU University Medical Center, de Boelelaan 1089a, 1081 HV, Amsterdam, the Netherlands., Bril H; Department of Pathology, Spaarne Gasthuis, Boerhaavelaan 22, 2035 RC, Haarlem, the Netherlands., Stockmann HBAC; Department of Surgery, Spaarne Gasthuis, Boerhaavelaan 22, 2035 RC, Haarlem, the Netherlands., Jimenez CR; Department of Medical Oncology, OncoProteomics Laboratory, Amsterdam UMC, VU University Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands., Meijer GA; Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands., Fijneman RJA; Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands. Electronic address: r.fijneman@nki.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Feb; Vol. 144, pp. 91-100. Date of Electronic Publication: 2020 Dec 17.
Autor:
de Boo L; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Cimino-Mathews A; Departments of Pathology and Oncology, The Johns Hopkins Hospital, Baltimore, USA., Lubeck Y; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Daletzakis A; Biometrics Department, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Opdam M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Sanders J; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hooijberg E; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Rossum A; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Loncova Z; Division of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria., Rieder D; Division of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria., Trajanoski Z; Division of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria., Vollebergh M; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Sobral-Leite M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Coordenação de Pesquisa, Instituto Nacional de Câncer, Rio de Janeiro, RJ, Brazil., van de Vijver K; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, Ghent University Hospital, Ghent, Belgium., Broeks A; Core Facility Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Wiel R; Core Facility Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Tinteren H; Biometrics Department, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Linn S; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, University Medical Centre, Utrecht, the Netherlands., Horlings HM; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kok M; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: m.kok@nki.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Mar; Vol. 127, pp. 240-250. Date of Electronic Publication: 2020 Jan 16.